Clinical Trial Goal
To find out:
- The highest dose of AUTX-703 that's safe to give
- If AUTX-703 is safe and works well to treat AML or MDS that has relapsed or is refractory
You may be able to join this trial if you:
- Are 18 years old or older
- Have AML or MDS that has relapsed or is refractory
- Have not had a blood or marrow transplant (BMT) or CAR T-cell therapy in the last 2 months
- Do not have graft-versus-host-disease (GVHD)
- Agree to have other standard tests done to see if you can be in the clinical trial
Trial Details
AUTX-703 is a protein degrader that targets KAT2A/B on certain cells.
You’ll get:
You’ll get:
- AUTX-703 - A pill that you take by mouth up to 3 times each week
You'll have biopsies to see how well the treatment is working. The clinical trial doctors will check your health for up to 2 years.
The Food and Drug Administration (FDA) has not yet approved AUTX-703.
Locations
Sponsors
lead: Auron Therapeutics, Inc.
